BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 8616034)

  • 1. Secondary acute leukaemias with 11q23 rearrangement: clinical, cytogenetic, FISH and FICTION studies.
    Zhang Y; Poetsch M; Weber-Matthiesen K; Rohde K; Winkemann M; Haferlach T; Gassmann W; Ludwig WD; Grote W; Löffler H; Schlegelberger B
    Br J Haematol; 1996 Mar; 92(3):673-80. PubMed ID: 8616034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992.
    Andersen MK; Christiansen DH; Jensen BA; Ernst P; Hauge G; Pedersen-Bjergaard J
    Br J Haematol; 2001 Sep; 114(3):539-43. PubMed ID: 11552977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.
    Rowley JD; Reshmi S; Sobulo O; Musvee T; Anastasi J; Raimondi S; Schneider NR; Barredo JC; Cantu ES; Schlegelberger B; Behm F; Doggett NA; Borrow J; Zeleznik-Le N
    Blood; 1997 Jul; 90(2):535-41. PubMed ID: 9226152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry.
    Baer MR; Stewart CC; Lawrence D; Arthur DC; Mrózek K; Strout MP; Davey FR; Schiffer CA; Bloomfield CD
    Leukemia; 1998 Mar; 12(3):317-25. PubMed ID: 9529125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia.
    Abdou SM; Jadayel DM; Min T; Swansbury GJ; Dainton MG; Jafer O; Powles RL; Catovsky D
    Leuk Lymphoma; 2002 Jan; 43(1):89-95. PubMed ID: 11911106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
    Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
    Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children.
    Felix CA; Hosler MR; Winick NJ; Masterson M; Wilson AE; Lange BJ
    Blood; 1995 Jun; 85(11):3250-6. PubMed ID: 7756657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.
    Wuchter C; Harbott J; Schoch C; Schnittger S; Borkhardt A; Karawajew L; Ratei R; Ruppert V; Haferlach T; Creutzig U; Dörken B; Ludwig WD
    Leukemia; 2000 Jul; 14(7):1232-8. PubMed ID: 10914547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A DNA probe combination for improved detection of MLL/11q23 breakpoints by double-color interphase-FISH in acute leukemias.
    von Bergh A; Emanuel B; van Zelderen-Bhola S; Smetsers T; van Soest R; Stul M; Vranckx H; Schuuring E; Hagemeijer A; Kluin P
    Genes Chromosomes Cancer; 2000 May; 28(1):14-22. PubMed ID: 10738298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemia.
    Sait SN; Claydon MA; Conroy JM; Nowak NJ; Barcos M; Baer MR
    Cancer Genet Cytogenet; 2007 Sep; 177(2):143-6. PubMed ID: 17854671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute leukaemia and myelodysplastic syndromes with chromosomal rearrangement involving 11q23 locus, but not
    Zuo W; Wang SA; DiNardo C; Yabe M; Li S; Medeiros LJ; Tang G
    J Clin Pathol; 2017 Mar; 70(3):244-249. PubMed ID: 27496968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations.
    Drexler HG; Quentmeier H; MacLeod RA
    Leukemia; 2004 Feb; 18(2):227-32. PubMed ID: 14671638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
    Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M
    Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5.
    Poirel H; Rack K; Delabesse E; Radford-Weiss I; Troussard X; Debert C; Leboeuf D; Bastard C; Picard F; Veil-Buzyn A; Flandrin G; Bernard O; Macintyre E
    Blood; 1996 Mar; 87(6):2496-505. PubMed ID: 8630416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis.
    Dreyling MH; Schrader K; Fonatsch C; Schlegelberger B; Haase D; Schoch C; Ludwig W; Löffler H; Büchner T; Wörmann B; Hiddemann W; Bohlander SK
    Blood; 1998 Jun; 91(12):4662-7. PubMed ID: 9616163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site.
    Slater DJ; Hilgenfeld E; Rappaport EF; Shah N; Meek RG; Williams WR; Lovett BD; Osheroff N; Autar RS; Ried T; Felix CA
    Oncogene; 2002 Jul; 21(30):4706-14. PubMed ID: 12096348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
    Broeker PL; Super HG; Thirman MJ; Pomykala H; Yonebayashi Y; Tanabe S; Zeleznik-Le N; Rowley JD
    Blood; 1996 Mar; 87(5):1912-22. PubMed ID: 8634439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HRX gene rearrangement in secondary acute lymphoblastic leukemia.
    Kobayashi Y; Hayashi Y; Ozawa K; Asano S
    Leuk Lymphoma; 1995 May; 17(5-6):391-9. PubMed ID: 7549829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rearrangement of the MLL gene in acute myeloblastic leukemia: report of two rare translocations.
    Douet-Guilbert N; Morel F; Le Bris MJ; Herry A; Morice P; Bourquard P; Banzakour S; Le Calvez G; Marion V; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2005 Mar; 157(2):169-74. PubMed ID: 15721641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of t(11;19)(q23;p13.3) by fluorescence in situ hybridization analysis in a pediatric patient with therapy-related acute myelogenous leukemia.
    Cheng L; Ramesh KH; Radel E; Ratech H; Wei D; Cannizzaro LA
    Cancer Genet Cytogenet; 2001 Aug; 129(1):17-22. PubMed ID: 11520560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.